Upgrade to SI Premium - Free Trial

Pfizer (PFE) Target Increases at BMO Capital Following a Good Quarter

May 4, 2016 6:59 AM
BMO Capital analyst, Alex Arfaei, raised his PT on Pfizer (NYSE: PFE) to $40 (from $39) but admitted that much ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles